New Strategy Study of Functional Cure of Chronic Hepatitis B
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
As HBsAg clearance is uncommon in chronic hepatitis B (CHB) patients on nucleoside analogues
(NAs) therapy. The purpose of this study is to optimize HBsAg clearance in CHB Patients with
sequential treatment of pegylated interferon alpha-2b and NAs.